Search 450+ indications across 30+ countries. EpiLansis gives you validated patient numbers, funnels, and disease burden in one cloud platform.
Thelansis has supported teams at
Most teams still build epidemiology from scattered sources. EpiLansis gives you one consistent, traceable view.
Shorter timelines from question to answer
Pool size, disease burden, and unmet needs
Assets and segments with the strongest potential
High-burden geographies ranked first
Five connected views of every patient population, all from one traceable data set.
Broken down by age, sex, and sub-population, and updated as new evidence is published.
Follow prevalent patients through to eligible, and see where they drop out.
Compare burden, diagnosis gaps, and unmet need across markets.
Time to diagnosis, care settings, switching, and stopping.
Current therapies and patient share by line of treatment.
Explore online, or take the numbers with you.
Explore by country, segment, and year
Feed the numbers into your own models
For medical and clinical teams
For strategy and leadership reviews
For commercial and forecasting teams
Peer-reviewed journals, registries, claims datasets, and national health reports.
The AI engine extracts and summarizes the literature, then shows evidence ranges with the assumptions stated.
KOL interviews, clinical panels, and practice-pattern checks, followed by medical and statistical review.
Results arrive as dashboards, reports, or exports, and update as publications, disease definitions, and treatment patterns change.
Prioritize the pipeline and check trial feasibility
Build treated patient pools and forecast inputs
Back pricing and HTA files with burden evidence
Size licensing and investment opportunities fast
Start client work from validated numbers
Pick a day that works. A Thelansis specialist will tailor the demo to your patients and markets.
We’ll confirm , by email to within one business day.
Each Thelansis Strategy Product answers one core forecasting question.
Epidemiology, patient funnels, and disease burden across 30+ countries.
Uptake benchmarks from comparable launches.
Peer-reviewed journals, registries, claims datasets, and national health reports. Figures are validated through KOL interviews, clinical panels, and expert medical and statistical review.
EpiLansis is updated continuously. It tracks new publications, changes in disease definitions, and shifts in treatment patterns.
Our team builds custom reports and adjusts scope on demand, so you can still get the numbers you need.
Book a demo and we’ll walk you through the platform and set up access. Existing users can log in at epilansis.com.
Turn data into decision-ready intelligence with EpiLansis.
Fill in your details and our expert consultants will get in touch with you.